DOI QR코드

DOI QR Code

Efficacy Test of Polycan, a Beta-Glucan Originated from Aureobasidium pullulans SM-2001, on Anterior Cruciate Ligament Transection and Partial Medial Meniscectomy-Induced-Osteoarthritis Rats

  • Kim, Joo-Wan (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Cho, Hyung-Rae (Glucan Corp. Research Institute, Marine Biotechnology Center) ;
  • Ku, Sae-Kwang (Department of Anatomy and Histology, College of Oriental Medicine, Daegu Haany University)
  • Received : 2011.10.26
  • Accepted : 2011.11.21
  • Published : 2012.02.28

Abstract

The object of this study was to assess the efficacy of Polycan from Aureobasidium pullulans SM-2001, which is composed mostly of beta-1,3-1,6-glucan, on osteoarthritis (OA)-induced by anterior cruciate ligament transection and partial medial meniscectomy (ACLT&PMM). Three different dosages of Polycan (85, 42.5, and 21.25 mg/kg) were orally administered once a day for 84 days to male rats a week after ACLT&PMM surgery. Changes in the circumference and maximum extension angle of each knee, and in cartilage histopathology were assessed using Mankin scores 12 weeks after Polycan administration. In addition, cartilage proliferation was evaluated using bromodeoxyuridine (BrdU). As the result of ACLT&PMM, classic OA was induced with increases in maximum extension angles, edematous knees changes, and capsule thickness, as well as decreases in chondrocyte proliferation, cartilages degenerative changes, and loss of articular cartilage. However, these changes (except for capsule thickness) were markedly inhibited in all Polycan- and diclofenac sodium-treated groups compared with OA control. Although diclofenac sodium did not influence BrdU uptake, BrdU-immunoreactive cells were increased with all dosages of Polycan, which means that Polycan treatment induced proliferation of chondrocytes in the surface articular cartilage of the tibia and femur. The results obtained in this study suggest that 84 days of continuous oral treatment of three different dosages of Polycan led to lesser degrees of articular stiffness and histological cartilage damage compared with OA controls 91 days after OA inducement, suggesting that the optimal Polycan dosage to treat OA is 42.5 mg/kg based on the present study.

Keywords

References

  1. Appleton, C. T., D. D. McErlain, V. Pitelka, N. Schwartz, S. M. Bernier, J. L. Henry, et al. 2007. Forced mobilization accelerates pathogenesis: Characterization of a preclinical surgical model of osteoarthritis. Arthritis Res. Ther. 9: R13. https://doi.org/10.1186/ar2120
  2. Armstrong, S., R. Read, and P. Ghosh. 1994. The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J. Rheumatol. 21: 680-688.
  3. Arsever, C. L. and G. G. Bole. 1986. Experimental osteoarthritis induced by selective myectomy and tendotomy. Arthritis Rheum. 29: 251-261. https://doi.org/10.1002/art.1780290214
  4. Badley, E. M., I. Rasooly, and G. K. Webster. 1994. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: Findings from the 1990 Ontario Health Survey. J. Rheumatol. 21: 505-514.
  5. Badley, E. M. 1995. The effect of osteoarthritis on disability and health care use in Canada. J. Rheumatol. Suppl. 43: 19-22.
  6. Bendele, A. M. and S. L. White. 1987. Early histopathologic and ultrastructural alterations in femorotibial joints of partial medial meniscectomized guinea pigs. Vet. Pathol. 24: 436-443. https://doi.org/10.1177/030098588702400511
  7. Camplejohn, K. L. and S. A. Allard. 1988. Limitations of safranin 'O' staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies. Histochemistry 89: 185-188. https://doi.org/10.1007/BF00489922
  8. Cao, L., I. Youn, F. Guilak, and L. A. Setton. 2006. Compressive properties of mouse articular cartilage determined in a novel micro-indentation test method and biphasic finite element model. J. Biomech. Eng. 128: 766-771. https://doi.org/10.1115/1.2246237
  9. Carlsson, G. E. and T. Oberg. 1974. Remodelling of the temporomandibular joints. Oral Sci. Rev. 6: 53-86.
  10. Dougados, M., M. Nguyen, L. Berdah, B. Mazieres, E. Vignon, and M. Lequesne. 2001. Evaluation of the structure-modifying effects of diacerhein in hip osteoarthritis. Arthritis Rheum. 44: 2539-2547. https://doi.org/10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T
  11. Ehrlich, M. G., H. J. Mankin, H. Jones, A. Grossman, C. Crispen, and D. Ancona. 1975. Biochemical confirmation of an experimental osteoarthritis model. J. Bone Joint Surg. Am. 57: 392-396. https://doi.org/10.2106/00004623-197557030-00018
  12. Felson, D. T., R. C. Lawrence, P. A. Dieppe, R. Hirsch, C. G. Helmick, J. M. Jordan, et al 2000. Osteoarthritis: New insights. Part 1: The disease and its risk factors. Ann. Intern. Med. 133: 635-646. https://doi.org/10.7326/0003-4819-133-8-200010170-00016
  13. Felson, D. T. and T. Neogi. 2004. Osteoarthritis: Is it a disease of cartilage or of bone? Arthritis Rheum. 50: 341-344. https://doi.org/10.1002/art.20051
  14. Fernihough, J., C. Gentry, M. Malcangio, A. Fox, J. Rediske, T. Pellas, et al. 2004. Pain-related behaviour in two models of osteoarthritis in the rat knee. Pain 112: 83-93. https://doi.org/10.1016/j.pain.2004.08.004
  15. Galois, L., S. Etienne, L. Grossin, A. Watrin-Pinzano, C. Cournil-Henrionnet, D. Loeuille, et al. 2004. Dose-response relationship for exercise on severity of experimental osteoarthritis in rats: A pilot study. Osteoarthr. Cartil. 12: 779-786. https://doi.org/10.1016/j.joca.2004.06.008
  16. Ganey, T., J. Libera, V. Moos, O. Alasevic, K. G. Fritsch, H. J. Meisel, and W. C. Hutton. 2003. Disc chondrocyte transplantation in a canine model: A treatment for degenerated or damaged intervertebral disc. Spine 28: 2609-2620. https://doi.org/10.1097/01.BRS.0000097891.63063.78
  17. Gencosmanoglu, B. E., M. Eryavuz, and S. Dervisoglu. 2001. Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res. Exp. Med. (Berl.) 200: 215-226.
  18. Goldberg, V. M. and J. A. Buckwalter. 2005. Hyaluronans in the treatment of osteoarthritis of the knee: Evidence for diseasemodifying activity. Osteoarthr. Cartil. 13: 216-224. https://doi.org/10.1016/j.joca.2004.11.010
  19. Guo, J. S., L. Ou, J. Zhou, X. J. Wang, and X Guo. 2006. Impact on the model of rat osteoarthritis of jingu tablet. Zhongguo Zhong Yao Za Zhi 31: 232-235.
  20. Hayami, T., M. Pickarski, G. A. Wesolowski, J. Mclane, A. Bone, J. Destefano, et al. 2004. The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 50: 1193-1206. https://doi.org/10.1002/art.20124
  21. Hayami, T., M. Pickarski, Y. Zhuo, G. A. Wesolowski, G. A. Rodan, and T. Duong Le. 2006. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38: 234-243. https://doi.org/10.1016/j.bone.2005.08.007
  22. Henry, J. L. 2004. Molecular events of chronic pain: From neuron to whole animal in an animal model of osteoarthritis. Novartis Found. Symp. 260: 139-145.
  23. Hoedt-Schmidt, S., A. Scheid, and D. A. Kalbhen. 1989. Histomorphological and lectin-histochemical confirmation of the antidegenerative effect of diclofenac in experimental osteoarthrosis. Arzneimittelforschung 39: 1212-1219.
  24. Hwang, Y. I., Y. B. Yoo, and S. H. Baik. 2000. Comparative study of rat thyroid regeneration using PCNA and BrdU immunohistochemistry. Korean J. Anat. 33: 247-254.
  25. Ito, T., H. Mitui, N. Udaka, H. Hayashi, K. Okudela, M. Kanisawa, and H. Kitamura. 1998. Ki-67 (MIB 5) immunostaining of mouse lung tumors induced by 4-nitroquinoline 1-oxide. Histochem. Cell Biol. 110: 589-593.
  26. Janusz, M. J., A. M. Bendele, K. K. Brown, Y. O. Taiwo, L. Hsieh, and S. A. Heitmeyer. 2002. Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthr. Cartil. 10: 785-791. https://doi.org/10.1053/joca.2002.0823
  27. Kahveci, Z., F. Z. Minbay, and L. Cavusoglu. 2000. Safranin O staining using a microwave oven. Biotech. Histochem. 75: 264-268. https://doi.org/10.3109/10520290009085130
  28. Kalbhen, D. A. 1987. Chemical model of osteoarthritis: A pharmacological evaluation. J. Rheumatol. 14: 130-131.
  29. Kamekura, S., K. Hoshi, T. Shimoaka, U. Chung, H. Chikuda, T. Yamada, et al. 2005. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil. 13: 632-641. https://doi.org/10.1016/j.joca.2005.03.004
  30. Kim, H. D., H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, B. R. Park, et al. 2006. Effect of exopolymers from Aureobasidium pullulans on formalin-induced chronic paw inflammation in mice. J. Microbiol. Biotechnol. 16: 1954-1960.
  31. Kim, H. D., H. R. Cho, S. B. Moon, H. D. Shin, K. J. Yang, B. R. Park, et al. 2007. Effects of ${\beta}$-glucan from Aureobasidium pullulans on acute inflammation in mice. Arch. Pharm. Res. 30: 323-328. https://doi.org/10.1007/BF02977613
  32. Kohn, D. F. and S. W. Barthold. 1984. Biology and diseases of rats, pp. 91-122. In J. G. Fox, B. J. Cohen, and F. M. Loew (eds.). Laboratory Animal Medicine. Academic Press, Inc., Orlando.
  33. Kopp, S., C. Mejersjo, and E. Clemensson. 1983. Induction of osteoarthrosis in the guinea pig knee by papain. Oral Surg. Oral Med. Oral Pathol. 55: 259-266. https://doi.org/10.1016/0030-4220(83)90325-0
  34. Layton, M. W., C. Arsever, and G. G. Bole. 1987. Use of the guinea pig myectomy osteoarthritis model in the examination of cartilage-synovium interactions. J. Rheumatol. 14: 125-126.
  35. Livne, E., K. von der Mark, and M. Silbermann. 1985. Morphologic and cytochemical changes in maturing and osteoarthritic articular cartilage in the temporomandibular joint of mice. Arthritis Rheum. 28: 1027-1238. https://doi.org/10.1002/art.1780280910
  36. Lovasz, G., S. H. Park, E. Ebramzadeh, P. D. Benya, A. Llinas, A. Bellyei, et al. 2001. Characteristics of degeneration in an unstable knee with a coronal surface step-off. J. Bone Joint Surg. Br. 83: 428-436. https://doi.org/10.1302/0301-620X.83B3.9674
  37. Marshall, K. W. and A. D. Chan. 1996. Arthroscopic anterior cruciate ligament transection induces canine osteoarthritis. J. Rheumatol. 23: 338-343.
  38. McDevitt, C., E. Gilbertson, and H. Muir. 1977. An experimental model of osteoarthritis; early morphological and biochemical changes. J. Bone Joint Surg. Br. 59: 24-35.
  39. Moore, E. E., A. M. Bendele, D. L. Thompson, A. Littau, K. S. Waggie, B. Reardon, and J. L. Ellsworth. 2005. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthr. Cartil. 13: 623-631. https://doi.org/10.1016/j.joca.2005.03.003
  40. Pastoureau, P. C., A. C. Chomel, and J. Bonnet. 1999. Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis. Osteoarthr. Cartil. 7: 466-473. https://doi.org/10.1053/joca.1999.0241
  41. Patel, N. A., J. Zoeller, D. L. Stamper, J. G. Fujimoto, and M. E. Brezinski. 2005. Monitoring osteoarthritis in the rat model using optical coherence tomography. IEEE Trans. Med. Imaging 24: 155-159. https://doi.org/10.1109/TMI.2004.839360
  42. Pavelka, K., J. Gatterova, M. Olejarova, S. Machacek, G. Giacovelli, and L. Rovati. 2002. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch. Intern. Med. 162: 2113-2123. https://doi.org/10.1001/archinte.162.18.2113
  43. Rezende, M. U., H. M. Gurgel, P. R. Vilaca Jr., R. K. Kuroba, A. S. Lopes, R. Z. Phillipi, and A. J. Hernandez. 2006. Diacerhein versus glucosamine in a rat model of osteoarthritis. Clinics 61: 461-466.
  44. Roberts, M. J., S. B. Adams Jr., N. A. Patel, D. L. Stamper, M. S. Westmore, S. D. Martin, et al. 2003. A new approach for assessing early osteoarthritis in the rat. Anal. Bioanal. Chem. 377: 1003-1006. https://doi.org/10.1007/s00216-003-2225-2
  45. Schwartz, E. R. and R. A. Greenwald. 1979. Experimental models of osteoarthritis. Bull. Rheum. Dis. 30: 1030-1033.
  46. Schwartz, E. R. 1987. Animal models: A means to study the pathogenesis of osteoarthritis. J. Rheumatol. 14: 101-103.
  47. Seo, H. P., J. M. Kim, H. D. Shin, T. K. Kim, H. J. Chang, B. R. Park, and J. W. Lee. 2002. Production of -1,3/1,6-glucan by Aureobasidium pullulans SM-2001. Korean J. Biotechnol. Bioeng. 17: 376-380.
  48. Shin, H. D., K. J. Yang, B. R. Park, C. W. Son, H. J. Jang, and S. K. Ku. 2007. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition 23: 853-860. https://doi.org/10.1016/j.nut.2007.08.011
  49. Shoji, H., R. D. D'Ambrosia, E. J. Dabezies, R. F. Taddonio, J. Pendergrass, and A. G. Gristina. 1978. Articular cartilage and subchondral bone changes in an experimental osteoarthritic model. Surg. Forum 29: 554-556.
  50. Silbermann, M. 1976. Experimentally induced osteoarthrosis in the temporomandibular joint of the mouse. Acta Anat. (Basel) 96: 9-24. https://doi.org/10.1159/000144658
  51. Song, H. B., D. C. Park, G. M. Do, S. L. Hwang, W. K. Lee, H. S. Kang, et al. 2006. Effect of exopolymers of Aureobasidium pullulans on improving osteoporosis induced in ovariectomized mice. J. Microbiol. Biotechnol. 16: 37-45.
  52. Stoop, R., P. Buma, P. M. van der Kraan, A. P. Hollander, R. C. Billinghurst, T. H. Meijers, et al. 2001. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthr. Cartil. 9: 308-315. https://doi.org/10.1053/joca.2000.0390
  53. Tang, X., D. L. Falls, X. Li, T. Lane, and M. B. Luskin. 2007. Antigen-retrieval procedure for bromodeoxyuridine immunolabeling with concurrent labeling of nuclear DNA and antigens damaged by HCl pretreatment. J. Neurosci. 27: 5837-5844. https://doi.org/10.1523/JNEUROSCI.5048-06.2007
  54. Tran, D., M. Golick, H. Rabinovitz, D. Rivlin, G. Elgart, and B. Nordlow. 2000. Hematoxylin and safranin O staining of frozen sections. Dermatol. Surg. 26: 197-199. https://doi.org/10.1046/j.1524-4725.2000.09220.x
  55. Wei, L., A. Hjerpe, B. H. Brismar, and O. Svensson. 2001. Effect of load on articular cartilage matrix and the development of guinea-pig osteoarthritis. Osteoarthr. Cartil. 9: 447-453. https://doi.org/10.1053/joca.2000.0411

Cited by

  1. Allograft ligament transplantation in anterior cruciate ligament reconstruction patients with meniscal tears vol.134, pp.4, 2012, https://doi.org/10.1007/s00402-014-1929-4
  2. Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1:9 weight ratio, on rats with surgery-induced osteoarthritis vol.9, pp.5, 2012, https://doi.org/10.3892/etm.2015.2332
  3. Characterization and enzymatic hydrolysis of hydrothermally treated β-1,3-1,6-glucan from Aureobasidium pullulans vol.32, pp.12, 2012, https://doi.org/10.1007/s11274-016-2167-4
  4. Selection of the optimal herbal composition of pomegranate concentrated powder from aqueous extracts of Eucommiae Cortex and Achyranthis Radix to treat osteoarthritis in rats vol.38, pp.4, 2012, https://doi.org/10.13048/jkm.17037
  5. Extracellular polysaccharides purified from Aureobasidium pullulans SM-2001 (Polycan) inhibit dexamethasone-induced muscle atrophy in mice vol.41, pp.3, 2012, https://doi.org/10.3892/ijmm.2017.3251
  6. Anti-osteoporotic effects of mixed compositions of extracellular polymers isolated from Aureobasidium pullulans and Textoria morbifera in ovariectomized mice vol.18, pp.None, 2012, https://doi.org/10.1186/s12906-018-2362-y
  7. Anti-osteoarthritic effects of a combination of pomegranate concentrate powder, Eucommiae cortex and Achyranthis radix in rats vol.39, pp.4, 2018, https://doi.org/10.13048/jkm.18037
  8. A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/9750531
  9. Effects of Eleutherococcus Extract Mixture on Endochondral Bone Formation in Rats vol.20, pp.5, 2019, https://doi.org/10.3390/ijms20051253
  10. Effects of Pomegranate Concentrate Powder: Eucommiae Cortex: Achyranthis Radix 5:4:1 (w/w) Mixed Formula on Monosodium Iodoacetate-Induced Osteoarthritis in Rats vol.15, pp.3, 2012, https://doi.org/10.1177/1934578x20907725
  11. Anti-Osteoarthritic Effects of a Mixture of Dried Pomegranate Concentrate Powder, Eucommiae Cortex, and Achyranthis Radix 5:4:1 ( g / g ) in a Surgically Induced Osteoarthritic Rabbit Model vol.12, pp.3, 2012, https://doi.org/10.3390/nu12030852
  12. Biological Activity of High-Purity β-1,3-1,6-Glucan Derived from the Black Yeast Aureobasidium pullulans : A Literature Review vol.13, pp.1, 2021, https://doi.org/10.3390/nu13010242
  13. An overview of antioxidant capacity, total phenolics, and amino acids of Aureobasidium pullulans GM6 vol.45, pp.3, 2012, https://doi.org/10.1111/jfpp.15227
  14. Plebeian Sage (Salvia plebeia R. Br) Extract Ameliorates Inflammation and Cartilage Degradation in Surgically Induced Osteoarthritis Rats vol.12, pp.4, 2012, https://doi.org/10.3390/app12042030